These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20693307)

  • 1. Fecal occult blood testing has great potential as a screening tool for colorectal cancer.
    Dreyfuss JH
    CA Cancer J Clin; 2010; 60(5):275-6. PubMed ID: 20693307
    [No Abstract]   [Full Text] [Related]  

  • 2. Colon cancer screening strategies.
    Agrawal J; Syngal S
    Curr Opin Gastroenterol; 2005 Jan; 21(1):59-63. PubMed ID: 15687886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of immunological fecal occult blood testing for colorectal cancer screening.
    Nakama H; Kamijo N
    Prev Med; 1994 May; 23(3):309-13. PubMed ID: 8078851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal occult blood testing: clinical value and limitations.
    Simon JB
    Gastroenterologist; 1998 Mar; 6(1):66-78. PubMed ID: 9531118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance.
    Sharma VK; Corder FA; Raufman JP; Sharma P; Fennerty MB; Howden CW
    Am J Gastroenterol; 2000 Aug; 95(8):2068-73. PubMed ID: 10950059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does use of the Coloscreen Self-Test improve patient compliance with fecal occult blood screening?
    Park SI; Saxe JC; Weesner RE
    Am J Gastroenterol; 1993 Sep; 88(9):1391-4. PubMed ID: 8362837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
    Quintero E
    Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is fecal DNA testing superior to fecal occult-blood testing for colorectal cancer screening?
    Capellá G
    Nat Clin Pract Oncol; 2005 May; 2(5):234-5. PubMed ID: 16264954
    [No Abstract]   [Full Text] [Related]  

  • 9. [Screening for colorectal tumors using fecal occult blood studies].
    Restellini A; Margalith D; Bauerfeind P; Guyot J; Ollyo JB; Gonvers JJ; Blum AL
    Ther Umsch; 1989 Jun; 46(6):389-97. PubMed ID: 2667190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer screening: do we practice what we preach?
    Colquhoun P; Weiss EG; Efron J; Nogueras JJ; Vernava AM; Wexner SD
    Surg Innov; 2006 Jun; 13(2):81-5. PubMed ID: 17012147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
    Lieberman DA; Weiss DG;
    N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of fecal occult-blood screening on the incidence of colorectal cancer.
    Ransohoff DF; Pignone M
    N Engl J Med; 2001 Mar; 344(13):1022-3. PubMed ID: 11280325
    [No Abstract]   [Full Text] [Related]  

  • 13. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
    Sharma VK; Corder FA; Fancher J; Howden CW
    Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower specificity of occult-blood test on stool collected by digital rectal examination.
    Zhang B; Nakama H; Fattah AS; Kamijo N
    Hepatogastroenterology; 2002; 49(43):165-7. PubMed ID: 11949640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of fecal occult-blood testing.
    Bond JH; Mandel JS; Church TR
    N Engl J Med; 1998 Sep; 339(11):774-5. PubMed ID: 9742033
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of fecal occult-blood screening on the incidence of colorectal cancer.
    Allison JE
    N Engl J Med; 2001 Mar; 344(13):1022; author reply 1023. PubMed ID: 11280326
    [No Abstract]   [Full Text] [Related]  

  • 19. Fecal DNA for colorectal-cancer screening.
    Worthley DL; Cole SR; Young GP
    N Engl J Med; 2005 Mar; 352(13):1384-5; author reply 1384-5. PubMed ID: 15803528
    [No Abstract]   [Full Text] [Related]  

  • 20. [Physicians' reminders promote annual fecal occult blood testing compliance].
    Vinker S; Shumla V; Kitai E
    Harefuah; 2000 Jun; 138(12):1019-21, 1088, 1087. PubMed ID: 10979422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.